[Chemotherapy of bladder cancer].
D000818:Animals; D001761:Bleomycin / Q000008:administration & dosage; D002360:Carubicin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008937:Mitomycins / Q000008:administration & dosage; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011182:Postoperative Care; D011300:Preoperative Care; D013713:Teniposide / Q000008:administration & dosage; D013852:Thiotepa / Q000008:administration & dosage; D013721:Triethylenephosphoramide / Q000008:administration & dosage / Q000031:analogs & derivatives; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D008937:Mitomycins; D001761:Bleomycin; C015826:diiodobenzotepa; D004317:Doxorubicin; D003520:Cyclophosphamide; D013852:Thiotepa; D013713:Teniposide; D002360:Carubicin; D013721:Triethylenephosphoramide; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate
Khimioterapiia raka mochevogo puzyria.